Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1988 Dec;47(12):972–978. doi: 10.1136/ard.47.12.972

Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

C P Maury 1, L C Andersson 1, A M Teppo 1, S Partanen 1, E Juvonen 1
PMCID: PMC1003648  PMID: 3264697

Abstract

The pathogenesis of the anaemia associated with rheumatoid disease is unclear. It has previously been shown that the degree of the anaemia correlates with the severity of the inflammatory disease and that serum from patients with arthritis inhibits erythropoiesis. This study was designed to examine whether interleukin 1 could be a mediator of the anaemia in rheumatoid arthritis. Radioimmunoassay of interleukin 1 beta in serum showed that patients with rheumatoid arthritis and associated anaemia had significantly higher interleukin 1 beta concentrations than patients with rheumatoid arthritis without anaemia. Pure recombinant human interleukin 1 alpha and interleukin 1 beta, in concentration ranges similar to those found in the arthritic patients, markedly suppressed the colony formation of the erythroid, but not the granulocyte-macrophage progenitor cells in cultures of normal bone marrow. Natural human interleukin 1 and recombinant interleukin 1 beta, but not interleukin 1 alpha, suppressed in a dose dependent manner the proliferation of the human erythroleukaemia cell line (HEL) in cultures, suggesting that the interleukin 1 effect is a direct one. The results show that interleukin 1 is a humoral inhibitor of erythropoiesis and suggests that interleukin 1 is involved in the development of anaemia in association with rheumatoid arthritis.

Full text

PDF
972

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arenzana-Seisdedos F., Virelizier J. L., Fiers W. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol. 1985 Apr;134(4):2444–2448. [PubMed] [Google Scholar]
  2. Baracos V., Rodemann H. P., Dinarello C. A., Goldberg A. L. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983 Mar 10;308(10):553–558. doi: 10.1056/NEJM198303103081002. [DOI] [PubMed] [Google Scholar]
  3. Bendtzen K., Baek L., Berild D., Hasselbach H., Dinarello C. A., Wolff S. M. Demonstration of circulating leukocytic pyrogen/interleukin-1 during fever. N Engl J Med. 1984 Mar 1;310(9):596–596. doi: 10.1056/NEJM198403013100915. [DOI] [PubMed] [Google Scholar]
  4. Bentley D. P. Anaemia and chronic disease. Clin Haematol. 1982 Jun;11(2):465–479. [PubMed] [Google Scholar]
  5. Bevilacqua M. P., Pober J. S., Majeau G. R., Cotran R. S., Gimbrone M. A., Jr Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984 Aug 1;160(2):618–623. doi: 10.1084/jem.160.2.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Broxmeyer H. E., Williams D. E., Lu L., Cooper S., Anderson S. L., Beyer G. S., Hoffman R., Rubin B. Y. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol. 1986 Jun 15;136(12):4487–4495. [PubMed] [Google Scholar]
  7. Cannon J. G., Dinarello C. A. Increased plasma interleukin-1 activity in women after ovulation. Science. 1985 Mar 8;227(4691):1247–1249. doi: 10.1126/science.3871966. [DOI] [PubMed] [Google Scholar]
  8. Cannon J. G., Kluger M. J. Endogenous pyrogen activity in human plasma after exercise. Science. 1983 May 6;220(4597):617–619. doi: 10.1126/science.6836306. [DOI] [PubMed] [Google Scholar]
  9. Cartwright G. E., Lee G. R. The anaemia of chronic disorders. Br J Haematol. 1971 Aug;21(2):147–152. doi: 10.1111/j.1365-2141.1971.tb03424.x. [DOI] [PubMed] [Google Scholar]
  10. Dainiak N., Hardin J., Floyd V., Callahan M., Hoffman R. Humoral suppression of erythropoiesis in systemic lupus erythematosus (SLE) and rheumatoid arthritis. Am J Med. 1980 Oct;69(4):537–544. doi: 10.1016/0002-9343(80)90464-7. [DOI] [PubMed] [Google Scholar]
  11. Degliantoni G., Murphy M., Kobayashi M., Francis M. K., Perussia B., Trinchieri G. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med. 1985 Nov 1;162(5):1512–1530. doi: 10.1084/jem.162.5.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dinarello C. A., Cannon J. G., Wolff S. M., Bernheim H. A., Beutler B., Cerami A., Figari I. S., Palladino M. A., Jr, O'Connor J. V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986 Jun 1;163(6):1433–1450. doi: 10.1084/jem.163.6.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dinarello C. A. Interleukin-1. Rev Infect Dis. 1984 Jan-Feb;6(1):51–95. doi: 10.1093/clinids/6.1.51. [DOI] [PubMed] [Google Scholar]
  14. Dinarello C. A. Multiple biological properties of recombinant human interleukin 1 (beta). Immunobiology. 1986 Sep;172(3-5):301–315. doi: 10.1016/S0171-2985(86)80112-7. [DOI] [PubMed] [Google Scholar]
  15. Dinarello C. A., Wolff S. M. Molecular basis of fever in humans. Am J Med. 1982 May;72(5):799–819. doi: 10.1016/0002-9343(82)90548-4. [DOI] [PubMed] [Google Scholar]
  16. Dower S. K., Kronheim S. R., Hopp T. P., Cantrell M., Deeley M., Gillis S., Henney C. S., Urdal D. L. The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature. 1986 Nov 20;324(6094):266–268. doi: 10.1038/324266a0. [DOI] [PubMed] [Google Scholar]
  17. Ekblom P., Landschulz W., Andersson L. C. A lipophilic iron chelator induces an enhanced proliferation of human erythroleukaemia (HEL) cells. Scand J Haematol. 1986 Mar;36(3):258–262. doi: 10.1111/j.1600-0609.1986.tb01731.x. [DOI] [PubMed] [Google Scholar]
  18. Falkoff R. J., Muraguchi A., Hong J. X., Butler J. L., Dinarello C. A., Fauci A. S. The effects of interleukin 1 on human B cell activation and proliferation. J Immunol. 1983 Aug;131(2):801–805. [PubMed] [Google Scholar]
  19. Fibbe W. E., van Damme J., Billiau A., Goselink H. M., Voogt P. J., van Eeden G., Ralph P., Altrock B. W., Falkenburg J. H. Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood. 1988 Feb;71(2):430–435. [PubMed] [Google Scholar]
  20. Gowen M., Wood D. D., Ihrie E. J., McGuire M. K., Russell R. G. An interleukin 1 like factor stimulates bone resorption in vitro. Nature. 1983 Nov 24;306(5941):378–380. doi: 10.1038/306378a0. [DOI] [PubMed] [Google Scholar]
  21. Guilbert L. J., Iscove N. N. Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures. Nature. 1976 Oct 14;263(5578):594–595. doi: 10.1038/263594a0. [DOI] [PubMed] [Google Scholar]
  22. Iscove N. N., Sieber F., Winterhalter K. H. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol. 1974 Apr;83(2):309–320. doi: 10.1002/jcp.1040830218. [DOI] [PubMed] [Google Scholar]
  23. Kaushansky K., Lin N., Adamson J. W. Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation. J Clin Invest. 1988 Jan;81(1):92–97. doi: 10.1172/JCI113316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kronheim S. R., March C. J., Erb S. K., Conlon P. J., Mochizuki D. Y., Hopp T. P. Human interleukin 1. Purification to homogeneity. J Exp Med. 1985 Mar 1;161(3):490–502. doi: 10.1084/jem.161.3.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lachman L. B., Dinarello C. A., Llansa N. D., Fidler I. J. Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells. J Immunol. 1986 Apr 15;136(8):3098–3102. [PubMed] [Google Scholar]
  26. Lee G. R. The anemia of chronic disease. Semin Hematol. 1983 Apr;20(2):61–80. [PubMed] [Google Scholar]
  27. Lovett D., Kozan B., Hadam M., Resch K., Gemsa D. Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol. 1986 Jan;136(1):340–347. [PubMed] [Google Scholar]
  28. March C. J., Mosley B., Larsen A., Cerretti D. P., Braedt G., Price V., Gillis S., Henney C. S., Kronheim S. R., Grabstein K. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature. 1985 Jun 20;315(6021):641–647. doi: 10.1038/315641a0. [DOI] [PubMed] [Google Scholar]
  29. Martin P., Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science. 1982 Jun 11;216(4551):1233–1235. doi: 10.1126/science.6177045. [DOI] [PubMed] [Google Scholar]
  30. Matsushima K., Akahoshi T., Yamada M., Furutani Y., Oppenheim J. J. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta. J Immunol. 1986 Jun 15;136(12):4496–4502. [PubMed] [Google Scholar]
  31. Maury C. P. Interleukin 1 and the pathogenesis of inflammatory diseases. Acta Med Scand. 1986;220(4):291–294. doi: 10.1111/j.0954-6820.1986.tb02767.x. [DOI] [PubMed] [Google Scholar]
  32. Maury C. P., Teppo A. M. Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection. Clin Nephrol. 1984 Dec;22(6):284–292. [PubMed] [Google Scholar]
  33. Maury C. P., Teppo A. M. Serum immunoreactive interleukin 1 in renal transplant recipients. Association of raised levels with graft rejection episodes. Transplantation. 1988 Jan;45(1):143–147. doi: 10.1097/00007890-198801000-00031. [DOI] [PubMed] [Google Scholar]
  34. Maury C. P. Tumour necrosis factor--an overview. Acta Med Scand. 1986;220(5):387–394. doi: 10.1111/j.0954-6820.1986.tb02785.x. [DOI] [PubMed] [Google Scholar]
  35. Mizel S. B. Interleukin 1 and T cell activation. Immunol Rev. 1982;63:51–72. doi: 10.1111/j.1600-065x.1982.tb00411.x. [DOI] [PubMed] [Google Scholar]
  36. Männel D. N. Biological aspects of tumor necrosis factor. Immunobiology. 1986 Sep;172(3-5):283–290. doi: 10.1016/S0171-2985(86)80110-3. [DOI] [PubMed] [Google Scholar]
  37. Nouri A. M., Panayi G. S., Goodman S. M. Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol. 1984 Feb;55(2):295–302. [PMC free article] [PubMed] [Google Scholar]
  38. Oppenheim J. J., Shneyour A., Kook A. I. Enhancement of DNA synthesis and cAMP content of mouse thymocytes by mediator(s) derived from adherent cells. J Immunol. 1976 May;116(5):1466–1472. [PubMed] [Google Scholar]
  39. Palacios R., Ivhed I., Sideras P., Nilsson K., Sugawara I., Fernandez C. Accessory function of human tumor cell lines. I. Production of interleukin 1 by the human histiocytic lymphoma cell line U-937. Eur J Immunol. 1982 Oct;12(10):895–899. doi: 10.1002/eji.1830121018. [DOI] [PubMed] [Google Scholar]
  40. Peetre C., Gullberg U., Nilsson E., Olsson I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor. J Clin Invest. 1986 Dec;78(6):1694–1700. doi: 10.1172/JCI112764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pike B. L., Robinson W. A. Human bone marrow colony growth in agar-gel. J Cell Physiol. 1970 Aug;76(1):77–84. doi: 10.1002/jcp.1040760111. [DOI] [PubMed] [Google Scholar]
  42. Prouse P. J., Harvey A. R., Bonner B., Reid C. D., Ansell B. M., Gumpel M. Anaemia in juvenile chronic arthritis: serum inhibition of normal erythropoiesis in vitro. Ann Rheum Dis. 1987 Feb;46(2):127–134. doi: 10.1136/ard.46.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ramadori G., Sipe J. D., Dinarello C. A., Mizel S. B., Colten H. R. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med. 1985 Sep 1;162(3):930–942. doi: 10.1084/jem.162.3.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Reid C. D., Prouse P. J., Baptista L. C., Gumpel J. M., Chanarin I. The mechanism of the anaemia in rheumatoid arthritis: effects of bone marrow adherent cells and of serum on in-vitro erythropoiesis. Br J Haematol. 1984 Dec;58(4):607–615. doi: 10.1111/j.1365-2141.1984.tb06107.x. [DOI] [PubMed] [Google Scholar]
  45. Roodman G. D., Horadam V. W., Wright T. L. Inhibition of erythroid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease. Blood. 1983 Aug;62(2):406–412. [PubMed] [Google Scholar]
  46. Rosenwasser L. J., Dinarello C. A. Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation. Cell Immunol. 1981 Sep 1;63(1):134–142. doi: 10.1016/0008-8749(81)90034-4. [DOI] [PubMed] [Google Scholar]
  47. Rupp E. A., Cameron P. M., Ranawat C. S., Schmidt J. A., Bayne E. K. Specific bioactivities of monocyte-derived interleukin 1 alpha and interleukin 1 beta are similar to each other on cultured murine thymocytes and on cultured human connective tissue cells. J Clin Invest. 1986 Sep;78(3):836–839. doi: 10.1172/JCI112649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Schmidt J. A., Oliver C. N., Lepe-Zuniga J. L., Green I., Gery I. Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis. J Clin Invest. 1984 May;73(5):1462–1472. doi: 10.1172/JCI111350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Shou L., Schwartz S. A., Good R. A., Peng R., Chen C. L. A human soluble suppressor factor affecting lymphocyte responses in vitro. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6096–6100. doi: 10.1073/pnas.77.10.6096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sieff C. A. Hematopoietic growth factors. J Clin Invest. 1987 Jun;79(6):1549–1557. doi: 10.1172/JCI112988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Solomons N. W., Elson C. O., Pekarek R. S., Jacob R. A., Sandstead H. H., Rosenberg I. H. Leukocytic endogenous mediator in Crohn's disease. Infect Immun. 1978 Dec;22(3):637–639. doi: 10.1128/iai.22.3.637-639.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wood D. D., Bayne E. K., Goldring M. B., Gowen M., Hamerman D., Humes J. L., Ihrie E. J., Lipsky P. E., Staruch M. J. The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities. J Immunol. 1985 Feb;134(2):895–903. [PubMed] [Google Scholar]
  53. Zanjani E. D., McGlave P. B., Davies S. F., Banisadre M., Kaplan M. E., Sarosi G. A. In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. Br J Haematol. 1982 Mar;50(3):479–490. doi: 10.1111/j.1365-2141.1982.tb01944.x. [DOI] [PubMed] [Google Scholar]
  54. Zucali J. R., Dinarello C. A., Oblon D. J., Gross M. A., Anderson L., Weiner R. S. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest. 1986 Jun;77(6):1857–1863. doi: 10.1172/JCI112512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zucker S., Lysik R. M., DiStefano J. F. Cancer cell inhibition of erythropoiesis. J Lab Clin Med. 1980 Nov;96(5):770–782. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES